{"database": "lobbying", "table": "lobbying_activities", "rows": [[2861977, "1550ea0a-0881-417b-98a9-b9690e8c315f", "Q3", "HALL, RENDER, KILLIAN, HEATH & LYMAN, P.C.", 17352, "EISENHOWER HEALTH", 2022, "third_quarter", "MMM", "Site-Neutral Payment Reform; drug pricing legislation; health care regulatory issues; Coronavirus funding and regulatory issues; Medicare sequester and funding.", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2022-10-10T15:50:43-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2861977"], "units": {}, "query_ms": 15.470621990971267, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}